Drug interactions
Ipratropium-salbutamol + Triclabendazole
Severity: Moderate
Ipratropium-salbutamol and Triclabendazole: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Triclabendazole can prolong the QT interval, and salbutamol may add to arrhythmia risk through tachycardia and hypokalemia. The clinical risk is greatest with high salbutamol doses or other risk factors.
What this interaction means in plain words
Ipratropium-salbutamol and Triclabendazole can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Ipratropium-salbutamol belongs to Respiratory; Triclabendazole belongs to Anti Parasitic.
Why it happens
Additive QT prolongation, with beta-agonist-induced hypokalemia as a possible contributor.
What to do
Avoid excessive salbutamol use during triclabendazole treatment and correct electrolyte abnormalities. Consider ECG monitoring in patients with cardiac risk factors.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Ipratropium-salbutamol and Triclabendazole, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Ipratropium-salbutamol
Other interactions of Triclabendazole
Frequently asked questions
Can I take Ipratropium-salbutamol with Triclabendazole?
MediHelp rates the interaction as moderate. Ipratropium-salbutamol and Triclabendazole can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Triclabendazole can prolong the QT interval, and salbutamol may add to arrhythmia risk through tachycardia and hypokalemia. The clinical risk is greatest with high salbutamol doses or other risk factors.
How serious is the interaction between Ipratropium-salbutamol and Triclabendazole?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid excessive salbutamol use during triclabendazole treatment and correct electrolyte abnormalities. Consider ECG monitoring in patients with cardiac risk factors.
What other medicines interact with Ipratropium-salbutamol?
MediHelp also lists interactions of Ipratropium-salbutamol with, for example, Amisulpride, Arsenic trioxide, Carvedilol. The full list is on the Ipratropium-salbutamol page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
